We offer a novel tool for antibiotic treatment. Our approach targets a broad spectrum of bacteria but eliminates the risk of evolving resistance by targeting a multitude of pathways.

We have discovered new class of therapeutics that reduce the rate of cell growth in cancer and vascular lung diseases.

Safe Lactobacillus-based synthetic biologic as a colonization resistance agent of, and oral vaccine for, Clostridioides difficile infection (CDI).

An EVD or external ventricular drain, is a device used in neurosurgery to relieve intracranial pressure (ICP) resulting from a disturbance in cerebrospinal fluid (CSF) drainage due to tumors, cysts, bleeding, infection, hydrocephalus, and trauma. Existing EVD’s are manually assembled so as to insure appropriate drainage and ICP. Unfortunately, these systems are labor intensive and require full time monitoring by the medical staff.

Using today’s electronic devices and sensors, we have designed an EVD that can provide a completely autonomous solution while providing accuracy and repeatability.

We offer a novel topical treatment for ocular degeneration that restores neuronal function and vision with a simple eye drop.

Senfina offers in vivo whole life drug discovery services for aging and age-related diseases based on a multi-feature high-throughput imaging platform using C. elegans as a model organism.

Occult Tethered Cord Syndrome (TCS) is a serious medical condition often detected before birth. If the spinal cord is not free it can result in several other urological problems and can result in a life-long disability.

Stratofly Research seeks to deploy autonomous constellations of our patent-pending altitude-controlled high-altitude balloons (HABs) to collect higher fidelity in-situ atmospheric weather data in data-sparse areas such as over oceans, to improve weather forecasting.

Two of the HABs we manufacture do not require a lighter-than-air, reducing cost and complexity. Altitude-controlled HABs can autonomously adjust altitude to “ride” opposing winds at different altitudes for station-keeping over regions of interest and performing trajectory maneuvers.

With a 10x cost savings compared with current larger altitude-controlled HABs, these small low-cost HABs allow customers to deploy constellations of smaller payloads in the stratosphere, rather than one primary payload.